Filter
162
Text search:
ivermectin
Featured
Recommendations
23
New Publications
37
Language
Document type
No document type
61
Studies & Reports
37
Guidelines
36
Strategic & Response Plan
13
Manuals
6
Fact sheets
6
Training Material
1
Brochures
1
Infographics
1
Countries / Regions
Global
11
Uganda
7
Sierra Leone
6
Liberia
6
Ethiopia
6
Germany
5
Brazil
5
Latin America and the Carribbean
5
India
4
West and Central Africa
4
Middle East and North Africa
4
South Africa
3
Nigeria
2
Mozambique
2
East and Southern Africa
2
Africa
2
Congo, Democratic Republic of
1
Ghana
1
Philippines
1
South Sudan
1
Zambia
1
Kenya
1
Tanzania
1
Rwanda
1
Yemen
1
Paraguay
1
Solomon Islands
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
52
Clinical Guidelines
27
Public Health
13
Capacity Building
2
Women & Child Health
2
Key Resources
2
Pharmacy & Technologies
1
Toolboxes
NTDs
45
COVID-19
29
Pharmacy
9
Disability
3
Refugee
3
Mental Health
3
Caregiver
3
Ebola
2
Rapid Response
2
HIV
2
Social Ethics
2
Cholera
1
Conflict
1
AMR
1
Updated Treatment Guidelines
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose
...
23 March 2021
The meeting addressed the last key area, that is, determining the best method or combination of diagnostic methods for a control programme for S. stercoralis infections in humans.
Dr Montresor’s presentation highlighted that while there is currently no “gold standard” for the
...
With this World Health Day, WHO is drawing attention to a group of diseases that are spread by insects and other vectors, the heavy health and economic burdens they impose, and what needs to be done to reduce these burdens. Many of these diseases have been historically confined to distinct geographi
...
Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030 (“the road map”) sets explicit targets for the elimination of onchocerciasis by 2030, including eliminating the need for mass drug administration (MDA) of
...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown
...
WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended
Human strongyloidiasis is a chronic parasitic disease caused by infection with Strongyloides stercoralis, a soil-transmitted helminth that is estimated to infect 300–600 million people worldwide. This neglected tropical disease (NTD) is endemic globally, predominately in the South-East Asia, Afric
...
In South and Central America, lymphatic filariasis (LF) is caused by Wuchereria bancrofti, which is transmitted by Culex quinquefasciatus, the only vector species in this region. Of the seven countries considered endemic for LF in the Americas in the last decade, Costa Rica, Suriname and Trinidad a
...
Onchocerciasis causes skin and eye disease, visual impairment and neurological problems. It is mostly found in Africa, but also in Latin America and Yemen. The common name, ‘river blindness,’ gives a good indication where the disease can be found: the vector of the parasite, a small black fly of
...
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I
...
